Priveterra Acquisition Corp
Change company Symbol lookup
Select an option...
PMGM Priveterra Acquisition Corp
NVFY Nova LifeStyle Inc
GGIFF Garibaldi Resources Corp
MIGI Mawson Infrastructure Group Inc
GTIM Good Times Restaurants Inc
BENF Avalon Acquisition Inc
SOS Sos Ltd
HOFV Hall of Fame Resort & Entertainment Co
SCVL Shoe Carnival Inc
SNTG Sentage Holdings Inc

Company profile

Priveterra Acquisition Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The Company intends to focus on the medical technology sector. The Company has not commenced any business operations and has not generated any revenue.

Day's Change
0.09 (0.91%)
B/A Size
Day's High
Day's Low
(Heavy Day)

Today's volume of 40,765 shares is on pace to be much greater than PMGM's 10-day average volume of 36,101 shares.


Columbia Care Announces Co-Founder Michael Abbott's Transition to Chairman

4:05 pm ET March 16, 2023 (BusinessWire) Print

Columbia Care Inc. (NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) ("Columbia Care" or the "Company"), one of the largest and most experienced cultivators, manufacturers and retailers of cannabis products in the U.S., announced today the transition of Michael Abbott, Co-Founder of Columbia Care, from Executive Chairman to Chairman of the Board of Directors, effective immediately.

Michael Abbott co-founded Columbia Care with Chief Executive Officer Nicholas Vita in 2012 and helped build the Company into one of the largest multi-state medical and adult-use cannabis providers in the U.S. In his continuing role as Chairman, Abbott will remain integrally involved in company oversight and governance. Abbott noted, "It has been an honor and a privilege to work with Nick and the extraordinary team he has built around him over the past decade. I am deeply grateful for Nick's friendship and partnership as we endeavor to build a leading company in a burgeoning industry."

Vita commented, "I am very grateful that my partnership with Mike will continue, with him remaining the Chairman of our Board, which he has been ably leading since we became a public company in 2019. I look forward to continued collaboration with Mike and the rest of our Directors and to his ongoing involvement with the Company, as we strive to create shareholder value and positively impact the patients and customers we serve."

Jon May, the Lead Independent Director of the Board, also expressed his thanks for Abbott's contributions, "Mike has played a critical role in the Company's historical development and growth. In particular, he has been there for us at times of great difficulty, such as during the onset of the COVID-19 pandemic. For all of his contributions, I express my sincere thanks. I, too, look forward to continuing our work together on the Board."

About Columbia Care Columbia Care is one of the largest and most experienced cultivators, manufacturers and providers of cannabis products and related services, with licenses in 17 U.S. jurisdictions. Columbia Care operates 128 facilities including 95 dispensaries and 33 cultivation and manufacturing facilities, including those under development. Columbia Care is one of the original multi-state providers of medical cannabis in the U.S. and now delivers industry-leading products and services to both the medical and adult-use markets. In 2021, the company launched Cannabist, its new retail brand, creating a national dispensary network that leverages proprietary technology platforms. The company offers products spanning flower, edibles, oils and tablets, and manufactures popular brands including Seed & Strain, Triple Seven, Hedy, gLeaf, Classix, Press, and Amber. For more information on Columbia Care, please visit

Caution Concerning Forward-Looking Statements This press release contains certain statements that constitute "forward-looking information" or "forward-looking statements" within the meaning of applicable securities laws and reflect the Company's current expectations regarding future events. Forward-looking statements or information contained in this release include, but are not limited to, statements or information with respect to the executive management transition. These forward-looking statements or information, which although considered reasonable by the Company, may prove to be incorrect and are subject to known and unknown risks and uncertainties that may cause actual results, performance or achievements of the Company to be materially different from those expressed or implied by any forward-looking information. These risks, uncertainties and other factors include, among others, favorable operating and economic conditions; obtaining and maintaining all required licenses and permits; favorable production levels and sustainable costs from the Company's operations; and the level of demand for cannabis products, including the Company's products sold by third parties. In addition, securityholders should review the risk factors discussed under "Risk Factors" in Columbia Care's Form 10 dated May 9, 2022, filed with the applicable securities regulatory authorities and described from time to time in documents filed by the Company with Canadian and U.S. securities regulatory authorities.

View source version on

SOURCE: Columbia Care Inc.

Investor Contact 
Lee Ann Evans
Capital Markets 

Media Contact 
Lindsay Wilson
comtex tracking


Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.